Market Insider

Early movers: LULU, GM, TSLA, C, AAPL, BBRY & more

Getty Images

Check out which companies are making headlines before the bell:

Cal-Maine Foods–The nation's largest egg producer reported quarterly profit of $1.77 per share, trouncing estimates of $1.41, as it was able to command higher prices as well as continue to expand its specialty egg business.

Lululemon–Wedbush upgraded the stock to "outperform" from "neutral", saying bad news is already priced into the athletic apparel maker's stock and that it foresees a rebound in investor sentiment.

Panera Bread–Wedbush upgraded Panera to "outperform" from "neutral", as its checks indicate strong same store sales increases for the restaurant chain.

Tesla–The automaker reached agreement with New York State on how it may sell its cars. Tesla will be allowed to keep its five currently licensed retail locations, but additional locations will need to follow state dealer franchise laws.

General Motors—CEO Mary Barra will testify before Congress on the company's . GM expanded its recall Friday to 2.6 million vehicles, adding 917,000 more units.

FedEx–The company faces an expanded suit over its alleged illegal delivery of cigarettes to residential addresses. New York State has joined New York City in a suit that charges the delivery company with violating state and federal laws.

Apple–The tech giant will face an expanded suit involving e-books, with a federal judge granting class action certification to a consumer suit charging the company with conspiring to fix prices.

Citigroup–The battered mega bank was hurt by negligent auditing on its way to failing the latest Federal Reserve stress test, according to the Financial Times.

Novartis–The drug giant is ending a heart drug study early following strong results. The drug is designed to treat chronic heart failure.

Forest Labs–The company and Hungarian partner Gedeon Richter announced positive results in a study of their antipsychotic drug Cariprazine.

Medtronic–The medical device maker announced positive news about its non-surgical valve used to delay open heart surgery in children with congenital heart defects. A study showed the valve continued to work well in all but a few patients after a year.

BlackBerry–The smartphone maker banning Typo Products from selling a snap-on iPhone-like keyboard for BlackBerry handsets. Typo said it would appeal the ruling.

By CNBC's Peter Schacknow

Questions? Comments? Email us at